Skip to content

Risk Communication about Alternative Health Promotion Strategies

Risk Communication about Alternative Health Promotion Strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27996
Enrollment
600
Registered
2017-01-17
Start date
2017-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunization, informed decision making, risk communication,

Interventions

nvt

Sponsors

National Institute for Public Health and the Environment
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For this study the research population will consists of parents. To ensure representativeness of the study population and generalizability of the study results, heterogeneity of participants will be strived for. Accordingly, parents who have opted for following the NIP (child born between 2013 and 2014), parents who opted for partially following the NIP or on a different schedule (child born between 2013 and 2014), and parents who opted out of the NIP are approached for participation (child born between 2013 and 2014), and are registered with the Dutch immunization registry.

Exclusion criteria

Exclusion criteria: Parents who opted out or partially vaccinated their child due to illness or practical reasons.

Design outcomes

Primary

MeasureTime frame
Our project aims to identify decision-making factors regarding alternative health strategies by studying two cases: e-cigarette use, partial vaccination.

Secondary

MeasureTime frame
2.2.2 Objective 1. Identify the determinants of choices concerning best, second best and worst options and factors that may prevent counterproductive effects

Contacts

Public ContactKim Romijnders

National Institute for Public Health and the Environment (RIVM), Center for Health Protection (GZB)

kim.romijnders@rivm.nl+31 30 274 4512

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)